U.S. shows flexibility in clearing cancer drug
The Food and Drug Administration has approved a controversial drug meant as the last-ditch treatment for people with lung caner. The drug, AstraZeneca PLC's Iressa, is the first of a new class of
The Food and Drug Administration has approved a controversial drug meant as the last-ditch treatment for people with lung caner. The drug, AstraZeneca PLC's Iressa, is the first of a new class of